Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to -$2.1 million.

  • Ekso Bionics Holdings' Free Cash Flow rose 927.79% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.0 million, marking a year-over-year increase of 1064.04%. This contributed to the annual value of -$9.9 million for FY2024, which is 1906.48% up from last year.
  • As of Q3 2025, Ekso Bionics Holdings' Free Cash Flow stood at -$2.1 million, which was up 927.79% from -$3.5 million recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Free Cash Flow peaked at -$1.5 million during Q4 2024, and registered a low of -$4.3 million during Q1 2023.
  • Over the past 5 years, Ekso Bionics Holdings' median Free Cash Flow value was -$3.0 million (recorded in 2023), while the average stood at -$2.9 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first tumbled by 11030.0% in 2022, then skyrocketed by 5599.13% in 2023.
  • Ekso Bionics Holdings' Free Cash Flow (Quarter) stood at -$3.1 million in 2021, then dropped by 20.27% to -$3.7 million in 2022, then skyrocketed by 55.99% to -$1.6 million in 2023, then rose by 10.63% to -$1.5 million in 2024, then plummeted by 42.57% to -$2.1 million in 2025.
  • Its Free Cash Flow was -$2.1 million in Q3 2025, compared to -$3.5 million in Q2 2025 and -$2.0 million in Q1 2025.